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DOI 10.1016/j.str.2011.09.011SUMMARY 2008). By contrast, substantial decrease in SF has beenHuman glycolipid transfer protein (GLTP) fold repre-
sents a novel structural motif for lipid binding/trans-
fer and reversible membrane translocation. GLTPs
transfer glycosphingolipids (GSLs) that are key regu-
lators of cell growth, division, surface adhesion, and
neurodevelopment. Herein, we report structure-
guided engineering of the lipid binding features of
GLTP. New crystal structures of wild-type GLTP
and two mutants (D48V and A47DkD48V), each
containing bound N-nervonoyl-sulfatide, reveal
the molecular basis for selective anchoring of sulfa-
tide (3-O-sulfo-galactosylceramide) by D48V-GLTP.
Directed point mutations of ‘‘portal entrance’’ resi-
dues, A47 and D48, reversibly regulate sphingosine
access to the hydrophobic pocket via a mecha-
nism that could involve homodimerization. ‘‘Door-
opening’’ conformational changes by phenylalanines
within the hydrophobic pocket are revealed during
lipid encapsulation by new crystal structures of
bona fide apo-GLTP and GLTP complexed with
N-oleoyl-glucosylceramide. The development of
‘‘engineered GLTPs’’ with enhanced specificity for
select GSLs provides a potential new therapeutic
approach for targeting GSL-mediated pathologies.
INTRODUCTION
3-O-sulfogalactosylceramide or sulfatide (SF) is a major compo-
nent of the myelin sheath in the central and peripheral nervous
system in mammals. SF makes up 4%–6% of myelin lipids
and, together with its precursor galactosylceramide (GalCer),
accounts for more than half (50–60 wt%) of the outer surface
lipids of the myelin sheath (Eckhardt, 2008). Accumulation of
SF has been implicated in neurological diseases such as meta-
chromatic leukodystrophy (Eckhardt, 2008; Halder et al., 2007;
Jeon et al., 2008; Zeng et al., 2008), which often are character-
ized by progressive demyelination. Elevation of sulfatide by
30%–40% has also been found in the superior frontal and cere-
bellar gray matter in Parkinson’s disease patients (Eckhardt,1644 Structure 19, 1644–1654, November 9, 2011 ª2011 Elsevier Ltdobserved in a case of progressive epilepsy with mental retarda-
tion (Hermansson et al., 2005) and in the brain and cerebrospinal
fluid of Alzheimer’s disease patients (Eckhardt, 2008; Han, 2007;
2010). Not surprisingly, sulfatide homeostasis is critical for the
normal function of central and peripheral nerves. Nonetheless,
the metabolic alterations underlying the disease-linked changes
in sulfatide homeostasis remain poorly understood, especially
with respect to alterations in sulfatide inter- and intracellular traf-
ficking (Han, 2007). Mammalian glycolipid transfer proteins
(GLTPs) accelerate the intermembrane trafficking of various gly-
cosphingolipids (GSLs) including sulfatide (Sasaki, 1990; Brown
and Mattjus, 2007). In contrast, a fungal GLTP in Podospora
anserina has a narrower specificity for GSLs and transfers sulfa-
tide very poorly (Kenoth et al., 2010). Development of human
‘‘engineered GLTPs’’ with altered lipid binding features, such
as enhanced selectivity for sulfatide, could provide a potential
new avenue of biomedical therapy for targeting GSL-mediated
pathologies.
Previously, we determined the structure of human GLTP in
GSL-free form as well as complexed with various galactosyl-
and lactosylceramide species (GalCers and LacCers) (Malinina
et al., 2004; 2006). The studies showed the human GLTP-fold
to be unique among lipid binding/transfer proteins and serve
as the structural prototype that defines the GLTP superfamily.
To acquire GSL, GLTP utilizes: (1) a GSL recognition center to
selectively bind the sugar-amide head group via a specific
network of hydrogen-bond interactions, (2) a cleft-like gating
mechanism to facilitate lipid chain entry/exit into/out of the
hydrophobic pocket in the protein interior; (3) two modes of
GSL binding. In the GSL ‘‘sphingosine-in’’ mode, the acyl and
sphingosine lipid chains are both encapsulated within the
same hydrophobic pocket of GLTP. In the GSL ‘‘sphingosine-
out’’ mode, only the acyl chain occupies the hydrophobic pocket
while the sphingosine chain remains outside and cross-bridges
to a partner GLTP molecule, containing a similarly complexed
glycolipid, to form a dimer. Structure determination of GLTP
complexed with different GSLs has revealed that pocket occu-
pancy, optimal fit by the ceramide chains, and monomer/dimer
stability of the GLTP/GSL complex all play roles in determining
whether the GSL lipid-chain encapsulation mode is sphingo-
sine-in or sphingosine-out (Malinina et al., 2004; 2006). However,
the intrinsic molecular events most likely to function as primary
regulators of the GSL binding mode by GLTP, i.e., control theAll rights reserved
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pocket, as well as its expansion/contraction during lipid chain
encapsulation remain poorly understood, further complicating
the engineering of GLTPs with altered lipid binding features.
In the present study, we show that point mutation of ‘‘portal
entrance’’ residues in the human GLTP-fold can switch the
binding mode for lipid-chain encapsulation in a manner that
can be reversed by introduction of a second adjacent point
mutation. More remarkably, the GSL selectivity of the point-
mutated GLTP is enhanced by virtue of continued binding/trans-
fer of sulfatide, but not of simple neutral GSLs (e.g., GalCer) that
typically are most highly preferred by wt-GLTP. The molecular
basis for alteration of transfer selectivity in favor of sulfatide,
switching of the GLTP-GSL binding mode, and optimization of
hydrophobic pocket expansion/contraction are elucidated by
five new high resolution crystal structures of GSL-GLTP
complexes presented herein.
RESULTS AND DISCUSSION
Phe Cluster within apo-GLTP and Its Reshaping on GSL
Binding
The hydrophobic pocket that encapsulates the GSL hydro-
carbon chains is conformationally adaptable and highly
nonpolar (Malinina et al., 2004; 2006; Airenne et al., 2006). In
GLTP, seven of ten phenylalanine residues (33, 34, 42, 103,
107, 148, and 161) are grouped closely and line the hydrophobic
pocket, providing an endogenous marker for the main lipid
chain encapsulation region (region-I; circled area in Figure 1A).
Three other phenylalanine residues (183, 23, and 67) are more
distant and located in a separate, extended region (region-II;
long narrow ellipse in Figure 1A). Both region-I and region-II
are fully collapsed and contain no trace of bound hydrocarbon
chain, verifying this to be the first bona fide structure (1.5 A˚)
of human apo-GLTP (Table 1). In contrast, previously reported
‘‘glycolipid-free’’ GLTP structures all contain nonglycolipid
hydrocarbons near the junction of region-I and region-II (Mali-
nina et al., 2004, 2006; Airenne et al., 2006), possibly obscuring
some conformational changes that occur when the lipid chains
are encapsulated by the hydrophobic pocket (see Figure S1
available online).
Region-I is the major zone of GSL ceramide accommodation
where chains of various length and unsaturation can show two
bindingmodes: ‘‘sphingosine-in’’ or ‘‘sphingosine-out’’ (Malinina
et al., 2004, 2006). In Figure 1B, the sphingosine-in mode is
clearly evident in the crystal structure (1.4 A˚; Table 1) of GLTP
complexed with N-oleoyl-glucosylceramide (18:1-GlcCer; Fig-
ure 1C, top panel) verifying the ability of region-I to simulta-
neously accommodate both ceramide chains in side-by-side
alignment as originally reported for the GLTP/GSL structure
involving N-oleoyl-lactosylceramide (Malinina et al., 2004). The
fully extended 18:1 acyl chain approaches the Phe183 phenyl
ring but is too short to insert into region-II while the Phe148
and Phe33 side chains in region-I assume ‘‘open door’’ confor-
mations compared with apo-GLTP. In general, this repositioning
of the phenylalanine side chains in region-I has the net effect of
transforming the circular ‘‘Phe cluster’’ of apo-GLTP (Figure 1A)
to an elliptical Phe cluster (Figure 1B) for GLTP containing bound
N-oleoyl-glucosylceramide.Structure 19, 1644–16Hypotheses for Switching Lipid Chain Binding within
GLTP
Despite structural evidence indicating connectivity between
region-I and region-II (Figures 1A and 1B), the role of region-II
in lipid chain accommodation is unclear. Previously, we
observed that a naturally occurring GalCer with a nervonoyl
acyl chain (24:1), which is sufficiently long to reach region-II,
did not enter into it (Malinina et al., 2006). Instead, the long
acyl chain assumed a serpentine conformation within region-I
and, by so doing, obstructed entry of the sphingosine chain, re-
sulting in a sphingosine-out binding mode (Figure S3A). We
speculated that the cis-double-bond positioning between
carbons 15 and 16 in the 24:1 acyl chain (Figure 1C, bottom
panel) might interfere with chain entry into the narrow bottom
compartment (region-II), much like difficulties encountered
when attempting to ‘‘thread the eye of a needle.’’ In such situa-
tions, chances for success often are improved by slight loos-
ening of the hold on the thread and adjusting the ‘‘push
direction.’’ Accordingly, to switch the binding mode to sphingo-
sine-in, we hypothesized that weakened anchoring of the ceram-
ide amide would be needed at the ‘‘portal entrance’’ of the
hydrophobic pocket while preserving (or strengthening) both
portal opening and GSL head group anchoring. Development
of this hypothesis was facilitated by the new data for apo-
GLTP (1.5 A˚) and by superposition analysis against the new
high-resolution structure (1.4 A˚) of the GLTP/18:1-GlcCer
complex (Figure 1D) that reveal the side-chain interactions
controlling the dramatic changes in positioning of specific Phe
residues, i.e., ‘‘open door’’ conformations needed for unob-
structed entry of lipid hydrocarbon chains. In apo-GLTP (Fig-
ure 1D; red), the Phe148 ‘‘closed’’ conformation is aided by
hydrophobic contacts with side chains of Tyr132, Phe42, and
His140. Opening of this Phe148 door (Figure 1D; green) to
accommodate GSL hydrocarbon chain(s) requires head group
anchoring of GSL and disruption of hydrophobic contacts
involving Phe148-His140 and Phe148-Phe42. To attain
hydrogen bonding with the ceramide amide group, His140
moves ‘‘upward’’ and away from Phe148 (Figure 1D). To
compensate the energy loss associated with disruption of the
hydrophobic contacts, Phe148 undergoes stacking with the
Tyr132 phenol ring (Figure 1D) to achieve the open door confor-
mation. This movement also facilitates Phe42 ‘‘liberation,’’
creating additional space for sphingosine chain encapsulation.
Thus, hydrogen bonding of the ceramide amide group with
His140 is likely to be a critical initial step for triggering the mech-
anistic process that promotes accommodation of sphingosine
within GLTP hydrophobic pocket. The essential role of His140
in GLTP action is supported by the complete inactivation
observed in H140L-GLTP (Malinina et al., 2004).
Enhancing GLTP Selectivity for Sulfatide
In wt-GLTP, Asp48 and His140 interact via hydrogen bonding
through a water molecule and regulate the opening of the portal
entrance to the hydrophobic pocket. We considered mutations
that might weaken the anchoring of the ceramide amide at the
‘‘portal entrance’’ of the hydrophobic pocket while preserving
(or strengthening) portal opening and GSL head group
anchoring. We hypothesized that such mutational changes
also might increase GLTP selectivity for certain glycolipids.54, November 9, 2011 ª2011 Elsevier Ltd All rights reserved 1645
Figure 1. Role of Phenylalanine Residues in Human GLTP-Fold Functionality
(A and B) A comparison of the collapsed hydrophobic pocket of bona fide apo-GLTP versus the occupied and expanded hydrophobic pocket of GLTP complexed
with 18:1-GlcCer. Two differently ‘‘shaped’’ regions (I and II) containing phenylalanine ‘‘clusters’’ are outlined by dashed-lines. The protein chain is colored in red
for apo-GLTP (A), whereas in green in the complex with 18:1-GlcCer (B). 310 helices are colored silver. Glycolipid atoms are colored yellow, red and blue for
carbon, oxygen and nitrogen, respectively. Tryptophan and phenylalanine side chains are colored silver and gold.
(C) Glycolipid structures for N-oleoyl (18:1) glucosylceramide (top panel) and for N-nervonyl (24:1) 3-O-sulfo-galactosylceramide (bottom panel). Highlights
emphasize distinguishing features that affect accommodation mode by GLTP.
(D) ‘‘Door opening’’ mechanism for Phe148 shown by superimposition of apo-GLTP (colored red) and 18:1-GlcCer/GLTP complex (colored green), with glycolipid
colored as in (B). Two tryptophan residues are colored in silver; the wide, red-dashed lines symbolize the hydrophobic contacts between Phe148 and the three
neighboring side chains of Phe42, Tyr132, and His140 in apo-GLTP, while the green arrow emphasizes the Phe148/Tyr132 stacking interaction that occurs when
the hydrophobic pocket is occupied by the ceramide chains of 18:1-GlcCer. Dashed lines show hydrogen bonds; Asp48, the residue to bemutated, is highlighted
by a red circle. See also Figure S1.
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Sulfatide-Selective GLTP MutantGiven the inactivation encountered by H140 mutation, Asp48
and adjacent residues emerged as leading candidates for
directed mutation-based engineering. From the lipid stand-
point, we focused on 3-O-sulfo-galactosylceramide (sulfatide)
because wt-GLTP was known to transfer sulfatide and other
neutral or negatively charged GSLs (Sasaki, 1990). Although
D48V-GLTP mutant was known to transfer GalCer poorly (Mali-
nina et al., 2004; Malakhova et al., 2005), its ability to transfer
sulfatide was untested. The focus on sulfatide containing nervo-
noyl (24:1) acyl chains (24:1-SF) was based on the hypothesized
need to have an acyl chain sufficiently long to reach Region-II,
as well as to have sulfate present to maintain strong interac-
tion with the GLTP recognition center. Figure 1C (bottom panel)1646 Structure 19, 1644–1654, November 9, 2011 ª2011 Elsevier Ltdillustrates the chemical structure of 3-O-sulfo-GalCer including
the location of the negatively charged, sulfate group on the
galactose moiety.
To initially test our hypotheses, we compared the transfer
activity of wild-type GLTP with that of the D48V mutant. Real-
time intermembrane transfer kinetics of sulfatide and of GalCer
by D48V-GLTP and wt-GLTP were measured by Fo¨rster reso-
nance energy transfer (Figures 2A and 2B) using GSLs with
acyl chains containing omega-linked anthrylvinyl (AV) fluoro-
phores (Figure 2C). Whether the cleft-like gating mechanism of
glycolipid uptake by GLTP (Malinina et al., 2004) enables entry
of the bulky, nonpolar AV group into the hydrophobic pocket
remains unclear. Regardless, the approach is well establishedAll rights reserved
Table 1. X-Ray Data Collection and Refinement Statistics for Human GLTP Structures
Protein Ligand apo-GLTP
WT-GLTP
18:1 GlcCer
WT-GLTP
24:1 SF
D48V-GLTP
24:1 SF
D48VkA47D-GLTP
24:1 SF
Data collection
Space group P43212 P212121 C2 C2 C2
a (A˚) 82.21 50.66 74.97 77.97 76.87
b (A˚) 82.21 61.65 50.6 49.04 48.13
c (A˚) 148.28 67.21 65.43 62.63 69.08
b, () a = g = 90 90.0 90.0 118.5 125.0 123.8
Resolution (A˚) 50–1.5 (1.55–1.50)a 50–1.4 (1.45–1.40) 50–1.1 (1.15–1.1) 50–1.5 (1.55–1.50) 50–2.1 (2.15–2.1)
Rmerge (%) 7.2 (24.9) 5.2 (39.2) 8.0 (29.3) 6.1 (44.4) 5.0 (55.0)
I/sI 15.6 (4.6) 15.0 (2.6) 19.0 (3.67) 8.8 (2.0) 14.2 (2.9)
Completeness (%) 99.5 (98.1) 98.2 (90.4) 99.8 (99.5) 99.9 (99.9) 96.0 (93.7)
Redundancy 4.6 (3.1) 4.9 (3.6) 4.5 (2.6) 5.1 (3.2) 4.6 (4.6)
Refinement
Resolution (A˚) 15–1.5 15–1.4 15–1.1 15–1.5 15–2.1
No. reflections 76,833 39,019 96,462 28,741 10,513
Rwork/Rfree (%) 17.8/20.7 15.98/19.36 13.84/16.40 17.9/21.0 18.6/21.8
No. atoms
Protein 3329 1708 1679 1636 1660
GSL — 51 61 61 61
Water 877 294 415 180 42
B-factors
Protein 20.23 17.31 17.37 33.47 47.4
GSL — 24.68 24.21 34.3 44.62
Water 48.64 30.94 34.5 44.18 47.8
Rmsd
Bond lengths (A˚) 0.015 0.012 0.013 0.019 0.016
Bond angles () 1.46 1.54 1.55 1.62 1.57
PDB entry 3RWV 3S0K 3RZN 3S0I 3RIC
Rfree is calculated for 5% of randomly selected reflections excluded from refinement. Rmsd, root-mean-square deviation from ideal values.
a Values in parentheses are for the highest-resolution shell.
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(Brown and Mattjus, 2007). The outcomes are supported by
competition analyses involving the selective slowdown in AV-
glycolipid transfer rate by glycolipids with naturally occurring,
unaltered acyl chains (Figures S2A–S2D), as well as by transfer
assays involving radioactive sulfatide and GalCer (Figures S2E
and S2F). Remarkably, sulfatide transfer by wt-GLTP or by
D48V mutant proceeds moderately well (Figure 2B; Figures
S2A and S2E), in contrast to the deleterious effect of D48Vmuta-
tion on GalCer transfer and the highly efficient transfer of GalCer
by wt-GLTP. Ratiometric comparison of the initial kinetic transfer
rates of sulfatide/GalCer by D48V-GLTP and wt-GLTP indicates
a >50-fold enhancement in the transfer selectivity of D48V-GLTP
for sulfatide over GalCer (Figure 2B).
Structure of 24:1 Sulfatide Bound to Wild-Type GLTP
To elucidate the molecular basis for the enhanced specificity of
D48V-GLTP for sulfatide, we solved the crystal structures of both
wt-GLTP/24:1-sulfatide complex (1.1 A˚) and D48V-GLTP/24:1-
sulfatide complex (1.5 A˚). The crystallographic parameters are
summarized in Table 1. With wt-GLTP (Figure 3A), the 24:1-Structure 19, 1644–16sulfatide binding mode remains sphingosine-out, as also was
the case for wt-GLTP/24:1-GalCer (Malinina et al., 2006). The
conformations of bound 24:1-sulfatide (Figure 3A) and bound
24:1-GalCer in wt-GLTP (Figure S3A) are nearly identical and
differ significantly from the sphingosine-in conformation of 18:1
GlcCer bound to wt-GLTP (Figure 3B).
Anchoring of the 3-O-sulfated-Gal head group to the head
group recognition center of wt-GLTP occurs via a network of
intermolecular hydrogen bonds (Figure 3C) involving the same
residues (Asp48, Asn52, Lys55, His140, Tyr207, Trp96) as for
the Gal head group of GalCer (Figure S3B). The carboxy group
of Asp48 forms two bifurcated hydrogen bonds (Figure 3C) that
are also observed in other GLTP complexes with nonsulfated
GSLs (Malinina et al., 2004, 2006). However, there are differences
in the way that residues Asn52 and Lys55 interact with sulfatide
comparedwithGalCer. For instance, Asn52 undergoesbidentate
hydrogen bonding with the 2-OH group of galactose and the
OS1-atom of the sulfo-group in sulfatide (Figure 3C), rather
than with the 2-OH and 3-OH groups of galactose in GalCer (Fig-
ure S3B). The ε-amino group of Lys55 interacts withOS2-atomof
the sulfo-group rather than with the 3-OH group of galactose in54, November 9, 2011 ª2011 Elsevier Ltd All rights reserved 1647
Figure 3. Crystal Structure of Human Wild-Type GLTP in Complex
with N-Nervonoyl (24:1) Sulfatide
(A) Ribbon representation of human wt-GLTP showing 24:1-sulfatide bound in
the sphingosine-out mode.
(B) Superpositioned conformations 24:1-sulfatide (magenta) and 18:1-GlcCer
(orange) as bound by wt-GLTP.
(C) Anchoring of 3-O-sulfo-galactose head group of sulfatide to wt-GLTP
sugar recognition center residues. Hydrogen bonds are indicated by dashed
lines. The protein Ca-backbone is silver with gold side chains. Glycolipid
carbon atoms aremagenta colored. Oxygen atoms are red, nitrogen atoms are
blue, and the sulfur atom is green. ThewhiteW inside the gray circle represents
a water molecule.
(D) Electrostatic surface view (blue, positive; red, negative; gray, neutral) of the
wt-GLTP sugar head group recognition center occupied by 24:1-sulfatide
(space-filled and magenta colored). See also Figures S3 and S6.
Figure 2. Transfer Activity of Wild-Type GLTP and D48V-GLTP for
Sulfatide and Galactosylceramide
(A) Transfer of AV-glycolipid by wt-GLTP or D48V-GLTP (2 mg) as a function of
time. The increase in fluorescence emission at 415 nm (AV emission) occurs
because of decreased Fo¨rster resonance energy transfer that occurs as
AV-glycolipid is removed from donor vesicles containing 3-perylenoyl PC and
is transported to POPC acceptor vesicles, as described in Experimental
Procedures.
(B) Selectivity enhancement of D48V-GLTP for sulfatide compared with
wt-GLTP. The ratio of the initial rates of sulfatide and GalCer transfer by
D48V-GLTP is increased 50- to 70-fold compared with wt-GLTP. Determina-
tions are shown for three different protein levels (1, 2, and 3 mg of protein).
(C) Structure of 3-O-Sulfo-D-galactosyl-b1-10-N-[12-(9-anthryl)-11E-dodece-
noyl]-D-erythro-sphingosine (AV-sulfatide). See also Figure S2.
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1648 Structure 19, 1644–1654, November 9, 2011 ª2011 Elsevier LtdGalCer. Also, the sulfate-OS3-atom undergoes hydrogen-bond
bridging with the main chain oxygen of Gly89 through a highly
conserved water molecule (Figure 3C). Thus, all three OS-atoms
contribute to the hydrogen-bond network that anchors the sulfo-
group of sulfatide to the GLTP surface (Figure 3D).
Structure of 24:1 Sulfatide Bound to D48V-GLTP
As observed in the wt-GLTP/24:1-sulfatide complex (Figure 3C),
Asn52 forms bidentate hydrogen bonds with the 2-OH group
of galactose and the OS1-atom of the sulfo-group in the D48V-
GLTP/24:1-sulfatide complex (Figure 4A). However, the recogni-
tion center of D48V-GLTP (Figure 4A) reveals amissing hydrogen
bond between the ε-amino group of Lys55 and the sulfate
OS2-atom, as well as a lack of the two bifurcated hydrogen
bonds originating from Asp48 replacement with Val. Regardless,
3-O-sulfated GalCer still is transferred well by D48V-GLTP
even though GalCer is not (Figure 2B; Figure S2). Hence, the 3-
O-sulfo-group makes an essential contribution to sulfatideAll rights reserved
Figure 4. Crystal Structure of D48V-GLTP in
Complex with N-Nervonoyl (24:1) Sulfatide
(A) Anchoring of 3-O-sulfo-galactose head group of sul-
fatide to D48V-GLTP sugar recognition center residues.
Hydrogen bonds are indicated by dashed lines. The
protein Ca-backbone is silver with gold side chains.
Glycolipid carbon atoms are cyan colored. Oxygen atoms
are red, nitrogen atoms are blue, and the sulfur atom is
green. The white W inside the gray circle represents a
water molecule.
(B) Electrostatic surface view (blue, positive; red, negative;
gray, neutral) of the D48V-GLTP sugar head group
recognition center occupied by 24:1-sulfatide (space-
filled and cyan colored). Replacement residue Val48 and
complementary cavity for the sulfate group are highlighted
by red oval and red semioval, respectively. The yellow
arrow emphasizes the affected region of inter-molecular
contact associated with the D48V mutation.
(C) Ribbon representation (gold) of human D48V-GLTP
showing 24:1-sulfatide (cyan) bound in the sphingosine-in
mode.
(D) Superpositioned conformations 24:1-sulfatide (cyan)
as bound by D48V-GLTP and 18:1-GlcCer (orange) as
when bound by wt-GLTP.
(E) Sphingosine-in binding mode of 24:1-SF by D48V-
GLTP. The open door conformations of both Phe148 and
Phe33 enable occupancy of Regions I and II (dashed line)
by the long nervonoyl chain. See also Figures S4 and S6.
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Sulfatide-Selective GLTP Mutantanchoring in the recognition center of D48V-GLTP. This conclu-
sion is further supported by the severely weakened interaction
known for GalCer and D48V-GLTP (Malinina et al., 2004; Mala-
khova et al., 2005), which also involves the loss of the two bifur-
cated hydrogen bonds provided by D48. Without sulfate to
compensate and secure sugar head group anchoring, GalCer
binding becomes weak.
To elucidate the intermolecular contacts that account for the
favorable accommodation of sulfatide head group at the protein
surface, we compared surface topologies. The surface view of
D48V-GLTP (Figure 4B) reveals that the diminished hydrogen
bonding with sulfate by Lys55 results in repositioning and uncov-
ering of a cavity (highlighted by a red semicircle) that surrounds
the bulky sulfate and appears to aid in its anchoring to GLTP. The
cavity also is present in wt-GLTP/sulfatide complexes but the
increased H-bonding to sulfate by Lys55 results in partial
obstruction (Figure 3D). When GalCer lacks the 3-O-sulfo group,
Lys55 completely obstructs the cavity because of positioning for
hydrogen bonding with the 3-OH group of galactose (Malinina
et al., 2006). These findings show that Lys55 interaction with sul-
fatide in GLTP is more complex than a simple charge-charge
interaction among chemical groups.
The changes to GLTP surface topology brought about by
D48V mutation, which eliminates the bifurcated hydrogen bonds
to the 2-OH group of galactose and the amide group of ceramide
in sulfatide, are illustrated in Figures 3D and 4B. Comparison of
the van der Waals contacts between sulfatide and wt-GLTP (Fig-
ure 3D) or D48V-GLTP (Figure 4B) reveals significantly more free
space around the V48 residue (Figure 4B, yellow arrows)
because of the smaller volume of the valine side chain compared
with aspartic acid. In fact, water molecules occupy the liberatedStructure 19, 1644–16space. However, their positions and number (two or three) differ
in various crystals of D48V-GLTP complexed with sulfatide, indi-
cating that the D48V mutation diminishes the clamp-like hold of
D48/H140 observed for GSLs bound to GLTP at the ‘‘portal
entrance’’ of the hydrophobic pocket (Malinina et al., 2004;
2006) and liberates the ceramide region of sulfatide.
Switching of Lipid-Chain Encapsulation within GLTP
As hypothesized, introduction of the D48V mutation into human
GLTP resulted in switching of the 24:1-sulfatide binding mode to
sphingosine-in (Figure 4C). Overall, the conformation resembles
that of 18:1 GlcCer in wt-GLTP (Figure 4D). The initial segment of
the long nervonoyl acyl chain is straight in the D48V mutant
(Figures 4C and 4D), rather than S-shaped as in wt-GLTP
(Figures 3A and 3B), enabling the sphingosine chain to be
accommodated within the hydrophobic pocket rather than being
excluded. Moreover, the distal portion of the 24:1 acyl chain
occupies region-II of D48V-GLTP (Figure 4E; Figures S4A and
S4B). It is noteworthy that the sharp bend that enables the distal
portion of the 24:1 acyl chain to enter region-II corresponds to
the location of the cis double bond. The open door conformation
of phenyl ring of Phe33 allows clear passage of the distal portion
of the 24:1 acyl chain into region-II (Figure 4E) and simulta-
neously shields this portion of acyl chain from outside hindrance
(Figures S4A and S4C).
A Hot Spot for Homodimerization in D48V-GLTP
Although the sulfate-accommodating surface cavity of D48V-
GLTP explains how sulfatide can bind when GalCer cannot,
this mutant must display additional attributes to enable accom-
modation of 24:1-sulfatide by a sphingosine-in binding mode54, November 9, 2011 ª2011 Elsevier Ltd All rights reserved 1649
Figure 5. D48V Mutation Generates GLTP Dimeric Hot Spot near Portal Entrance of Hydrophobic Pocket
(A and B) Dimeric arrangements of 24:1-sulfatide/wt-GLTP (A) and 24:1-sulfatide/D48V-GLTP (B) with proteins shown in ribbon representation and glycolipids
shown in space-filling representation. WT-GLTP and D48V mutant are colored blue and gold, respectively. Glycolipid carbon atoms are colored magenta for
wt-GLTP and cyan for D48V-GLTP.
(C) Schematic superimposition of two dimeric arrangements, highlighting the different mutual monomer inclination in D48V-GLTP complex compared with
wt-GLTP.
(D and E) The boxed regions of (A) and (B) rotated by 90 degrees and amplified in (D) and (E) with residues Pro44, Ala47, Asp48, and Val48 shown in space-filling
and ball-and-stick representations. Twomolecules of the dimeric structures are subcolored differently to emphasize a weak protein-protein contact between two
Pro44 residues in the wt-GLTP dimer. The intermolecular contact region increases in D48V dimer as a result of formation of a larger hydrophobic contact surface.
(F) Superimpositions of two dimeric arrangements, highlighting the interaction-point of a protein partner in a dimer with 24:1-sulfatide sphingosine chain with
lipids and proteins colored as in (A) and (B).
Structure
Sulfatide-Selective GLTP Mutantcompared with wt-GLTP, which uses sphingosine-out binding.
The dimerization interfaces of the D48V-GLTP/sulfatide and
wt-GLTP/sulfatide complexes reveal subtle but potentially
important differences. The dimerization contact regions of GSL/
GLTP complexes generally coincide with their membrane inter-
action domains (Malinina et al., 2006; Kamlekar et al., 2010). In
theabsenceofmembranes, bindingof 24:1-sulfatidebywt-GLTP
or D48V-GLTP does promote homodimerization in solution as
determined by dynamic light scattering analyses (Table S1).
Role for Pro44 in Hydrophobic Interfacial Contacts
Figures 5A and 5B show the dimeric structures of wt-GLTP and
D48V-GLTP complexed with 24:1-sulfatide. The two structures
differ both in their lipid chain conformations and in the inclina-
tions of the monomers forming their dimerization interfaces.
The end result is a more open dimer conformation for the wt-
GLTP complex compared with D48V-GLTP (depicted schemat-
ically in Figure 5C).
The dimer interface involves helix-loop-helix contacts that are
associated primarily with a-helix 2 and its adjacent a1-2 loop.
Within this contact region, Pro44 is an especially important
residue that undergoes hydrophobic contact with its partner
Pro44 in the dimeric complex (Figures 5D and 5E). However, it
is noteworthy that the Pro44 side chain forms a single-residue
protein-protein contact in the wild-type dimer (Figure 5D),
whereas the dimerization interface of D48V-GLTP contains
a larger multiresidue hydrophobic contact area formed by1650 Structure 19, 1644–1654, November 9, 2011 ª2011 Elsevier LtdPro44, Ala47, and Val48 (Figure 5E). Since only one of the inter-
face residues differs in D48V-GLTP, we conclude that replace-
ment of Asp48 by Val48 facilitates the close proximity and inter-
locking along the dimer interface.
Pro44 also forms van der Waals contacts with the nonpolar
sphingosine chains of both partner lipid molecules in the dimeric
structure in the sphingosine-out binding mode (Malinina et al.,
2006). Figure 5F shows the contacts of Pro44 with a partner
sphingosine chain in the wt-GLTP complex compared with the
D48V-GLTP complex to emphasize that, if the sphingosine chain
remained in the out conformation in D48V-GLTP, Pro44 contacts
would be impossibly close in the D48V dimer. Thus, changes in
dimer conformation appear to facilitate the sphingosine-in
binding mode of 24:1-sulfatide in D48V-GLTP.
Redesign of Lipid Binding Mode in A47DkD48V Double
Mutant
To further test our idea, we introduced an adjacent negatively
charged aspartic acid into D48V-GLTP through mutation of
alanine-47 for aspartate, i.e., A47DkD48V double mutant GLTP.
We reasoned that the electrostatic repulsion originally provided
by Asp48 in wtGLTP (Figure 6A, left panel), would be restored
by insertion of A47D into D48V alongwith the open-dimer confor-
mation that promotes the sphingosine-out binding mode of 24:1
sulfatide. Figure 6A (middle panel) shows how the lost electro-
static repulsion in D48V-GLTP is replaced by the van der Waals
attraction of the hydrophobic residues. In contrast, in theAll rights reserved
Figure 6. Comparison of theOpenConformation and the Sphingosine-out BindingMode of 24:1-SF Found in A47DkD48VDimerwith Those of
WT-GLTP
(A) Schematic highlighting the distinctions in intermolecular interactions observed in dimers of wt-GLTP (left panel), D48V mutant (middle panel), and double
mutant A47DkD48V (right panel): the red-arrowed repulsion between two negatively charged residues Asp48 in wt-GLTP is replaced for the attraction of
hydrophobic residues in D48V mutant and restored in double mutant A47DkD48V by means of an additional mutation A47D.
(B) The open arrangement of the dimer in WT-GLTP and A47DkD48Vmutant with conserved local negative charge of dimeric hot spot versus close conformation
of neutral D48V mutant.
(C) Similarity of the sphingosine-out binding mode in dimeric WT-GLTP and A47DkD48V mutant.
(D) Lipid dimers ‘‘derived’’ from the dimeric arrangements of WT-GLTP (left panel), D48V mutant (middle panel), and double mutant A47DkD48V (right panel).
Glycolipids and amino acids are shown in stick representations, proteins are indicated schematically. Coloring is blue, gold and white for WT-GLTP, D48Vmutant
and A47DkD48V mutant, respectively, and magenta, cyan and white for lipid derived from WT-GLTP, D48V mutant and A47DkD48V mutant, respectively, with
red, blue and green colors indicating atoms of oxygen, nitrogen and sulfur. See also Figure S5.
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Sulfatide-Selective GLTP MutantA47DkD48V double mutant, the repulsion provided by the newly
created aspartic acid, D47, (Figure 6A, right panel) restores the
open-dimer conformation. Figure 6B illustrates the dimer transi-
tions from open (wtGLTP; yellow) to closed (D48V-GLTP; blue)
and back to open (A47DkD48V-GLTP; white) in schematic
fashion, whereas Figure 6C displays the similar (but not identical)
mutual orientations of interacting sulfatide molecules in the open
dimers of wtGLTP and A47DkD48V-GLTP. Figure 6D shows the
spatial arrangement of the three sulfatide,sulfatide pairs and
the engineered transitions induced in the complexes of wtGLTP
(left panel; sphingosine-out), D48V-GLTP (middle panel; sphin-
gosine-in), and A47DkD48V-GLTP (right panel, sphingosine-
out). The overall structure of the A47DkD48V double mutant
GLTP with its ‘‘restored’’ sphingosine-out 24:1-sulfatide is illus-
trated in Figure S5.Structure 19, 1644–16Recognition center Adaptability for Sulfated-GSL Head
Groups
Nearly all residues known to comprise the sugar head group
recognition center of GLTP play essential roles in binding of sul-
fatide, including Asp48, Asn52, His140, and Trp96. The only
exception is Lys55, which would be expected to use its ε-amino
group to interact strongly with the 3-O-sulfo moiety of sulfatide in
both wt-GLTP and D48V-GLTP. However, this clearly is not the
case, especially for D48V-GLTP (Figure 4A), where a special
surface cavity with a complementary contact surface for the
3-O-sulfo-group (Figure 4B) becomes visible when Lys55 repo-
sitions. The complementary cavity seems to play a key role in
anchoring the negatively charged, sulfate group to the GLTP
surface. A conserved water molecule was discovered that
hydrogen bonds with the oxygen atom of Gly89 and undergoes54, November 9, 2011 ª2011 Elsevier Ltd All rights reserved 1651
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Sulfatide-Selective GLTP Mutanttight van der Waals contacts with the NH-group of Gly89 and the
Cb-atom of Leu92 (Figures 3C and 4A). The water molecule
favorably shapes the surface cavity for complementary contact
with the 3-O-sulfo-group (Figures 3D and 4B). The water mole-
cule is present in all apo-and holo-forms of human GLTP
resolved to date.
Intriguingly, a water molecule is also observed at the same
location in a GLTP-like protein (PDB 2Q52) from thermoacido-
philic unicellular red algae, Galdieria sulphuraria (Figure S6).
The conserved nature of this water molecule is illustrated in
Figure S6B, which shows theG. sulphurariaGLTP-fold superpo-
sitioned against human wt-GLTP complexed with sulfatide.
Although the lipid composition ofG. sulphuraria does not include
3-O-sulfo-GalCer, a ‘‘virtual’’ sulfatide is well accommodated,
suggesting binding of an analogous sulfoglycolipid. Surface
views of G. sulphuraria GLTP-fold (Figure S6C) and human
GLTP (Figure S6A) show similar outward projecting con-
formations for Lys66/55, respectively, further emphasizing the
similarity in shape and size of the potential sulfo-group inter-
action site.
Uniqueness of GLTP among Sulfatide Binding Proteins
It is noteworthy that our high-resolution structures of sulfatide
complexed with wtGLTP, D48V-GLTP, and A47DkD48V-GLTP
(Table 1) differ substantially from the structures of two other
proteins known to bind sulfatide, sulfatide/saposin B (2.2 A˚)
and sulfatide-CD1a (2.15 A˚). The hydrogen-bond interaction
network responsible for the recognition specificity of the 3-O-
sulfo-galactose and ceramide moieties distinguishes the GLTP
complexes (Figures 3C and 4A) from the corresponding CD1a
complex, which uses fewer hydrogen-bond recognition contacts
(Zajonc et al., 2003, 2005; Zajonc and Kronenberg, 2007). In the
case of saposin B, uncertainties in the specific features of the
lipid conformation prevented detailed analysis of the protein–
lipid interactions in this complex (Ahn et al., 2003). In the CD1a
complex, the sphingoid-base and N-acyl chains insert into sepa-
rate interconnecting hydrophobic pockets, whereas a single
hydrophobic pocket accommodates one or both lipid chains in
the GLTP complex. For saposin B, protein dimerization is
needed for formation of the hydrophobic cavity that accommo-
dates both hydrocarbon chains of sulfatide. These unique glyco-
lipid-protein interactions appear to be associated with distinct
functional events, namely, glycolipid transfer by the GLTP, in
contrast to glycolipid presentation by the CD1 major histocom-
patibility proteins, as well as by saposin B.
Conclusions
The engineering of proteins with enhanced stabilities, ligand
specificities, and functionalities is a rapidly emerging field with
potential applications in biotechnology and biomedical thera-
peutics (Hancock et al., 2009; Gaj et al., 2011; Picollo et al.,
2009;Wo¨rsdo¨rfer et al., 2011). Our structure-guided, point muta-
tional engineering of human GLTP illustrates how a detailed
understanding of structure-function relationships can enable
the development of ‘‘designer GLTPs’’ with enhanced selectivity
for certain GSLs. The five new high-resolution crystal structures
of human GLTP presented herein provide unprecedented
insights into the workings of the hydrophobic pocket of the
human GLTP-fold. Most notably, our data reveal the molecular1652 Structure 19, 1644–1654, November 9, 2011 ª2011 Elsevier Ltdbasis for the enhanced selectivity of D48V-GLTP for sulfatide
but not its nonsulfated precursor, which is very well accommo-
dated bywild-type GLTP. The protein surface cavity that accom-
modates the sulfo-group is formed at the junction of two alpha-
helices and involves a conserved water molecule. Our data
establish the functionality of a narrow bottom compartment of
the GLTP hydrophobic pocket and demonstrate that structure-
guided, point mutational redesign of GLTP can switch the
binding mode of lipid chains. Taken together, the five new
high-resolution GLTP structures provide unprecedented insights
into the molecular changes that optimize and regulate the
expansion/contraction of the hydrophobic pocket during lipid
accommodation.
Gaining an understanding of the structural principles that
enable human GLTP to selectively transfer certain GSLs
provides a new avenue for creating ‘‘designer GLTPs’’ with
highly targeted specificity, thus facilitating the development of
potential new therapeutic applications for the treatment of
GSL-related neurodegenerative diseases.
EXPERIMENTAL PROCEDURES
Plasmid Construction and Mutagenesis
The ORF encoding human GLTP (NCBI GenBank accession no. AF209704)
was subcloned into the pET-30 Xa/LIC expression vector (Novagen) by ligation
independent cloning, enabling cleavage of the N-terminal His6-S-tag to yield
protein identical in sequence to native GLTP. The site-directed D48V-GLTP
mutant was obtained using QuikChange Site-Directed Mutagenesis Kit (Stra-
tagene) and verified by sequencing.
Protein Expression and Purification
Transformed BL21 (DE3) cells (Novagen) were grown in Luria-Bertani medium
at 37C, induced with 0.1 mM IPTG, and grown an additional 16–20 hr at 15C.
Wild-type GLTP and D48V-GLTP were purified from soluble lysate by
Ni-affinity chromatography as detailed previously (Malakhova et al., 2005).
His- and S-tag sequences were removed using Factor-Xa and GLTP was
repurified by FPLC size exclusion chromatography using a HiLoad 16/60
Superdex-75 prep grade column (Amersham Biosciences).
Crystallization and X-Ray Data Collection
Crystals of wild-type-GLTP and D48V-GLTP complexed with 24:1 SF, as well
as apo-GLTP and GLTP complexed with 18:1 GlcCer, were grown by the
hanging-drop vapor-diffusion method using PEG 3350 or 8000 (15%–20%)
as precipitant and 100 mM MES (pH 5–7) containing 150 mM NaCl as buffer
(Malinina et al., 2004, 2006). All lipids were obtained from Avanti Polar Lipids
(Alabaster AL). Protein-lipid complexes were prepared by mixing protein and
lipid in 1:1 molar ratio using lipids dissolved in ethanol (final concentration
approximately 20% EtOH). Crystals were transferred into well solution con-
taining 20% glycerol as cryoprotectant, then mounted in a fiber loop, and
flash-frozen in a cold nitrogen stream. X-ray data were collected at 100K
using synchrotron radiation at ESRF (Grenoble, France) on beamlines ID
14-4 and ID 23-1, except for double mutant A47DkD48V-GLTP complexed
with 24:1-sulfatide which was collected at CICbioGUNE on X8 Proteum
System (Bruker) at CuKa wavelength 1.54 A˚ using a CCD detector. All data
were processed and scaled using the program suite HKL2000.
Structure Determination and Refinement
Crystals of apo-GLTP belonged to the P43212 space group, containing two
molecules in the asymmetric unit. The 18:1-GlcCer/GLTP complex crystallized
as a monomer with P212121 space group symmetry. Three other crystals be-
longed to the C2 space group and had one molecule of protein-lipid complex
in the asymmetric unit. All structures were determined by the Molecular
Replacement (MR) method, using the AMoRe program (Navaza, 1997) along
with previously refined complexes as models (Malinina et al., 2004; 2006).
Refinement was performed with REFMAC (Murshudov et al., 1997), alternatingAll rights reserved
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Sulfatide-Selective GLTP Mutantwith manual model-rebuilding using Turbo-Frodo and Coot. The ARP/wARP
automatic procedure was used to add solvent molecules (Lamzin and Wilson,
1993). Final structures were validated by PROCHECK. The coordinates have
been deposited in the Protein Data Bank. Data collection and refinement
statistics, along with unit cell dimensions, are summarized in Table 1.
Fluorescent Lipids
N-[(11E)-12-(9-anthryl)-11-dodecenoyl]-1-O-b-galactosylsphingosine (AV-
GalCer) and 1-acyl-2-[9-(3-perylenoyl)nonanoyl]-sn-glycero-3-phosphocho-
line (Per-PC)] were synthesized as described previously (Molotkovsky and
Bergelson, 1982; Molotkovsky et al., 1991). 3-O-sulfo-D-galactosyl-b1-10-N-
[(11E)-12-(9-anthryl)-11-dodecenoyl]-D-erythro-sphingosine (AV-sulfatide)
synthesis relied on a similar approach to be detailed elsewhere. 1-Palmitoyl-
2-oleoylphosphatidylcholine (POPC) was purchased from Avanti Polar Lipids.
The chemical structure of AV- sulfatide is shown in Figure 2C.
Fluorescence Lipid Transfer between Membranes
Real-time intermembrane transfer rates of fluorescent glycolipids by wt-GLTP
and D48V-GLTP were obtained by Fo¨rster resonance energy transfer using
a SPEX FluoroMax spectrofluorimeter (Horiba Scientific), with excitation and
emission band passes of 5 nm, and a stirred (approximately 100 rpm), temper-
ature-controlled (25 ± 0.1C) sample cuvette holder (Brown, 1992). Both fluo-
rescent lipids were localized initially to the donor vesicles, formed by rapid
ethanol injection and comprised of POPC plus 1 mole% AV-glycolipid and
1.5 mole% Per-PC. Minimal emission by AV-glycolipid occurred upon excita-
tion (370 nm) because of resonance energy transfer to nearby Per-PC. In
competition assays, donor vesicles also contained ‘‘competitor’’ lipids with
naturally occurring hydrocarbon chains at 1, 2, and 4 mole%. Addition of
approximately 10-fold excess of sonicated POPC acceptor vesicles produced
minimal change in fluorescence signal because of the very slow spontaneous
transfer of lipids with long acyl chains (Mattjus et al., 1999; Brown, 1992). Addi-
tion of catalytic GLTP amounts triggered a sudden, exponential increase in AV
emission intensity (415 nm) as the protein transported AV-labeled glycolipids
from donor vesicles to acceptor vesicles, creating separation from ‘‘nontrans-
ferable’’ Per-PC. Addition of detergent after extended incubation provided
a measure of maximum AV intensity achievable by ‘‘infinite’’ separation from
Per-PC. Nonlinear regression analyses using ORIGIN 7.0 software (Origin
Lab) provide the initial lipid transfer rate, no, for the first-order exponential
transfer process. Standard deviations were calculated at 95% confidence
interval. R2 values for all of the estimates were >0.96.
Preparation of Donor and Acceptor Vesicles
Donor vesicles composed of POPC (97.5 mole%), AV-glycolipid (1 mole%)
and Per-PC (1.5 mole%) were prepared by rapid ethanol injection into buffer
being rapidly stirred in the cuvette at 25C as described previously (Mattjus
et al., 1999). Prior to injection, all three lipids were mixed together in hexane,
dried under nitrogen, and then redissolved in ethanol (HPLC grade). Each
ethanol injection (5 ml) contained approximately 175 pmole of AV-glycolipid.
After dilution, the final ethanol concentration was less than 0.2%. The acceptor
vesicles were prepared in the following way. POPC was dried onto a glass
round bottom flask in vacuo before hydrating in sodium phosphate buffer
(pH 6.6) at 50mMconcentration and suspending by vortexing. The suspension
was probe sonicated intermittently under nitrogen until opalescent and then
centrifuged for 90 min at 100,000 3 g to remove probe particles and multila-
mellar vesicles. The size of the acceptor vesicle populations averaged approx-
imately 25 nm in diameter. The final acceptor vesicle concentration used in the
FRET lipid transfer assay was approximately 85 mM, which was 10- to 15-fold
higher than the donor concentration.
Dynamic Light Scattering
Dynamic light scattering (DLS) measurements were performed using a
DynaPro Titan instrument, Wyatt Technology Corporation (with laser of
approximately 830 nm wavelength). Studies were carried out in the protein
concentration range of 1–4 mg/ml in 150 mM NaCl, 20 mM Tris-Cl buffer (pH
8.0) at 18C. Complexes with lipid were prepared immediately prior to
measurement using protein:lipid ratios in complexes of 1:1. Prior to DLS, all
buffers were centrifuged at 27000 g for 30 min and filtered through 0.2 mm
membrane filters (Whatman). Data were collected and analyzed using theStructure 19, 1644–16DYNAMICS software for the DynaPro Titan instrument (Wyatt Technology
Corporation).ACCESSION NUMBERS
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